Methods: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera ® 1500 system. Results: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p 0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p 0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p 0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p 0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients (primary hypercholesterolemia, combined hyperlipidemia).
Introduction
Cardiovascular disease represents the major cause of death in Europe and is becoming increasingly common in developing countries. Such disorders arise from the progression of atherosclerosis, a chronic dis-that it does not take into consideration the central blood pressure value (central blood pressure is a prognostic factor predicting future cardiovascular events) 22) , and it has not yet been proven whether the CAVI is a marker of future cardiovascular disease 23) . Furthermore, CAVI measurements have been reported in patients with various cardiovascular risk factors, including obesity, diabetes mellitus, smoking, metabolic syndrome and essential hypertension [24] [25] [26] [27] [28] [29] . However, there is a limited information regarding the CAVI values in patients with different forms of dyslipidemia 30) .
Aim
The aim of this study was to evaluate whether the CAVI values differ between patients with DLP (primary hypercholesterolemia and combined hyperlipidemia) without diabetes mellitus and/or hypertension and healthy subjects.
Methods

Patient Groups
The studied population consisted of 510 retrospectively recruited subjects with primary hypercholesterolemia (PH) or combined hyperlipidemia (CH) 18 years of age or above from the outpatient department for lipid disorders who underwent regular control examinations between January 2011 and November 2012. Patients with a primary cause of secondary dyslipidemia (DLP), e.g. hypothyroidism, renal disease, uncontrolled diabetes mellitus, liver disease and alcoholism, were excluded. CH was defined as an offtreatment increase in the serum LDL-cholesterol, triglyceride and apolipoprotein B (type b hyperlipidemia) levels. PH was defined as an off-treatment increase in the serum LDL-cholesterol level with a normal triglyceride level (type a hyperlipidemia). The cut-off values for LDL-cholesterol (3.0 mmol/L), triglycerides (1.7 mmol/L) and apolipoprotein B (1.0 g/L) were determined in accordance with the ESC/ EAS Guidelines for the management of dyslipidaemia 31) and European guidelines for cardiovascular disease prevention in clinical practice 32) . Because the CAVI may be affected by hyperglycemia, diabetes mellitus and treatment with antidiabetic or antihypertensive agents 24, 26, [33] [34] [35] [36] , the data for a total of 185 patients who met the criteria for prediabetes or diabetes mellitus or who were being treated with antihypertensive drugs were excluded. The diagnosis of diabetes mellitus was made based on a venous plasma glucose level of ≥ 7.0 mmol/L or the use of antidiabetic drugs, and prediabetes was defined as a venous ease of the arteries that develops over many years without clinical symptoms, ultimately leading to narrowing of the artery with sudden obstruction. The causes of atherosclerosis are multifactorial. One of the most important risk factors is dyslipidemia, primarily a high level of LDL cholesterol. However, increased triglyceride levels and low HDL-cholesterol levels are also considered to be independent risk factors for cardiovascular disease 1, 2) . The progression of atherosclerosis may be decelerated, stopped or even reversed by intensive treatment targeting the main cardiovascular risk factors, primarily aggressive cholesterol-lowering therapy 3) . Therefore, the early detection of atherosclerosis using simple, quantitative and non-invasive assessments is very important for initiating early treatment and preventing further complications and cardiovascular events. One non-invasive method for detecting preclinical stages of atherosclerosis is a measurement of the brachial-ankle pulse wave velocity (PWV) 4, 5) . Evaluating the brachial-ankle PWV enables the clinician to assess the degree of both central elastic and peripheral muscular arterial stiffness, which have been shown to be predictors of coronary artery disease and may serve as prognostic factors of acute coronary syndrome 6, 7) . However, there are several limitations regarding measurements of the brachial-ankle PWV. For example, the reproducibility is relatively low, the method used to obtain the measurements is technically difficult and the results are affected by changes in blood pressure during the assessment 8, 9) . Moreover, the carotid-femoral PWV is recommended as a gold standard parameter for determining the degree of arterial stiffness, not the brachial-ankle PWV 10) . Recently, a new tool for measuring arterial wall stiffness, the cardio-ankle vascular index (CAVI), was introduced in order to overcome the dependence of PWV measurements on changes in blood pressure 11, 12) . The CAVI is measured using the VaSera ® device with sophisticated oscillometric technology. It has been reported that the CAVI is essentially independent of blood pressure due to the use of adjustments of the blood pressure values based on a stiffness parameter 8, 13) . The CAVI reflects the degree of stiffness of the thoracic, abdominal, common iliac, femoral and tibial arteries as a whole and, although is not a direct index, it is easy to obtain and reproducible 8, 11, [14] [15] [16] . It has also been demonstrated that the CAVI exhibits a close association with the extent of coronary atherosclerosis and the carotid intima-media thickness; therefore, it allows the physician to identify relatively early phases of atherosclerosis and may be used as a screening tool to quantify the subclinical atherosclerotic burden in asymptomatic subjects [17] [18] [19] [20] [21] . The disadvantage of CAVI is the fact analyzer (Roche, Basel, Switzerland) using commercially available kits. The total cholesterol and triglyceride levels were assayed according to the enzymatic colorimetric method (Roche Diagnostic GmBH), the HDL-cholesterol level was determined according to the homogenous method for direct measurements without precipitation (Sekisui Medical, Tokyo) and the apolipoprotein A1 and B levels were evaluated using an immunoturbidimetric assay. The LDL-cholesterol level was calculated according to the Friedewald equation 37) . We divided the patients into groups based on the smoking status according to self-reports. A smoker was defined as an individual with a history of smoking at least once during the last 12 months. Ex-smokers (having smoked more than 100 cigarettes in the individual's lifetime, with no cigarettes smoked during the last 12 months) and never-smokers were grouped together.
Cavi Measurements
The CAVI was measured using the VaSera ® 1500 system (Fukuda Denshi Co., Tokyo, Japan) according to the oscillometric method for blood pressure measurement. This system first measures the blood pressure of the right brachial and ankle followed by the left brachial and ankle. Hence, the arteries on the right and left side are alternately pressurized with the other side left open. This procedure not only reduces the burden on the examinee, but also enables the clinician to obtain more accurate measurements. The CAVI calculation method is based on the stiffness parameter obtained using the Bramwell-Hill equation 8, 38) . CAVI (InPs/Pd) 2 / P PWV 2 , where Ps and Pd are the systolic and diastolic blood pressure, respectively, PWV is the pulse wave velocity between the heart and ankle, is the blood density and P is the pulse pressure.
The CAVI values were measured by trained medical staff, with the participant resting in the supine position and his/her head held in the midline position. ECG and phonocardiography were monitored during the measurements. In order to limit the effects of diurnal variation, all subjects were examined at the same time of day, between 8:00 and 11:00 a.m. The examinations were conducted in a quiet room at a stable temperature of 21-22 .
Statistics
Standard descriptive statistics were applied in the analysis, including absolute and relative frequencies for categorical variables and the median with the 5th-plasma glucose level of 5.7-6.9 mmol/L. Another 77 patients were also excluded due to having a personal history of atherosclerotic disease (previous stroke or transient ischemic attack, previous angina pectoris or myocardial infarction, documented chronic ischemic heart disease, peripheral artery disease, cardiomyopathy or significant valvular disease, arrhythmia or heart failure). Finally, a total of 248 patients with DLP (104 men, 144 women) were selected.
Control Group
Data for a population-based cohort of 822 individuals 18 years of age or above selected randomly from the free-living general population of Brno city were included. Of these subjects, 285 were excluded because they did not meet the following inclusion criteria: no personal history of cardiovascular disease, hyperlipidemia, diabetes mellitus, liver and/or renal disease and no treatment with antihypertensive drugs. The remaining 537 individuals (244 men, 293 women) were included in the study.
All subjects evaluated in this study (both the dyslipidemic and control groups) were Caucasian and of Slavic origin. The study protocol complied with the Declaration of Helsinki and was approved by the Ethics Committee. Written informed consent was obtained from each participant at the beginning of the study.
Anthropometric Indices
Height and weight were measured by trained medical staff. All subjects wore only underwear, without shoes. Height was measured using a professional SECA stadiometer, with the head held in the Frankfort horizontal plane, and weight was determined using a calibrated professional high-precision SECA floor scale with the value rounded to the nearest 0.5 kg. Waist circumference was assessed at a level midway between the lower rib margin and the iliac crest at the end of expiration using a flexible, non-elastic scale, with the value rounded to the nearest 1.0 cm. BMI was calculated as weight (kg)/height squared (m 2 ).
Biomedical Markers
Blood pressure was measured twice (in a sitting position), once in the waiting room upon arrival and again after at least 10 minutes of rest, and the mean value was calculated. Blood samples for the laboratory analysis were obtained in the morning after 8-10 hours of fasting and sent to the laboratory within half an hour after collection. All laboratory tests were carried out at the same laboratory. The lipid and lipoprotein analyses were performed on a Modular SWA P300 higher BMI and waist circumference values (all p 0.01). However, no statistically significant differences were noted in the proportions of men/women or smokers/non-smokers between the groups. As expected, the total cholesterol, LDL-cholesterol, triglyceride and apolipoprotein B levels were higher and the HDL-cholesterol (all p 0.01) and apolipoprotein A1 (p 0.05) levels were lower in the DLP group than in the controls, whereas the systolic blood pressure and CAVI values were significantly increased in the DLP group (p 0.01).
PH was diagnosed in 162 and CH was diagnosed in 86 of the total 248 patients with DLP. There was a higher number of women in the PH group than in the control group (p 0.01); however, no differences were noted in the HDL-cholesterol and blood pressure values between these two groups. In contrast, there was a higher number of men in the CH group than in the control group (p 0.01), in addition to a greater number of smokers (p 0.05) and higher diastolic blood pressure values (p 0.01) ( Table 1) . The CAVI values were significantly increased in both the PH (p 0.01) and CH (p 0.01) groups in comparison to those 95th percentile range for continuous variables. Fisher's exact test was applied to determine the statistical significance of differences between the groups for binary variables, and the Mann-Whitney U test was employed for continuous variables. The propensity score method was used to create comparable groups matched according to the baseline characteristics, in which a linear regression model was adopted to further adjust the CAVI values for blood pressure. The level of statistical significance was set at 0.05 for all analyses. The IBM SPSS 21 for Windows (Release 21.0.0, IBM Corporation 2012) and R (R version 2.12.2 (2011-02-25), Copyright © 2011 The R Foundation for Statistical Computing) software programs with the "Susanne Stampf (2011) Nonrandom: Stratification and matching by the propensity score" package were used for the data analyses.
Results
The basic characteristics of the studied population are shown in Table 1 . The DLP patients were older than the control subjects and had significantly values in the CH group were increased compared to those seen in the controls at a borderline level of statistical significance (p 0.053). The results of the comparison of the balanced dataset for the PH and CH groups are presented in Table 5 . The HDL-cholesterol and LDL-cholesterol levels were significantly lower and the triglyceride levels (all p 0.001) and incidence of smokers (p 0.01) were higher in the CH group versus the PH group. Furthermore, the CAVI values were higher in the CH group (8.35, 95% CI 6.65; 10.10) than in the PH group (7.75, 95% CI 5.60; 10.00), although the difference was insignificant.
Discussion
It is well known that the progression of atherosclerosis is accelerated in patients with DLP in comparison to that seen in healthy populations 31) . One new tool for making the non-invasive diagnosis of atherosclerosis in the early stage is measurements of the CAVI, which essentially represents the stiffness of the aorta, femoral artery and tibial artery as a whole 11) . It observed in the control group. Considering the presence of statistically significant differences in age, gender and BMI between the patients and controls, the propensity score method with age, gender and BMI as covariates was used to create comparable groups matched according to the baseline characteristics. Due to the existence of statistically significant differences in diastolic blood pressure between some of the matched subjects and the unclear importance of the blood pressure in determining the CAVI, the results for both the CAVI and the diastolic blood pressure-adjusted CAVI are provided for these groups. The basic characteristics, laboratory data and CAVI values of the patients and controls in the balanced datasets are shown in Table 2 (DLP patients), Table 3 (PH) and Table 4 (CH). In comparison to that observed in the controls, the CAVI values were significantly increased in the DLP patients (p 0.004 and p 0.001 following adjustment for diastolic blood pressure). However, significant differences were not detected in the CAVI values between the control group and the PH and CH patient subgroups, although the CAVI waist circumference values. It has also been demonstrated that the CAVI increases linearly with age in both men and women and varies based on BMI and waist circumference 16, 30, [40] [41] [42] [43] [44] . Therefore, these factors are also confounding factors for the CAVI measurements, and their unbalanced structure among compared groups can induce bias in the analysis. In order to control for the effects of confounding factors, regression adjustment of the CAVI values and/or propensity score analyses to balance the structure of confounding factors between the compared groups should be adopted. Both methods have advantages and disadvantages. For example, regression adjustment preserves the number of patients in the dataset, although it may yield biased results if the confounding factors do not have an overlapping distribution between the analyzed groups. Meanwhile, although propensity score matching provides a fully balanced structure for confounding factors between the groups, it decreases the sample size due to the need to remove patients outside the has been reported that the CAVI is a sensitive index of preclinical and clinical atherosclerosis and may also indicate the degree of progression of carotid and coronary arteriosclerosis 9, 17) . Hence, the aim of this study was to evaluate whether the CAVI values differ significantly between healthy subjects and patients with DLP, particularly those with PH or CH. DLP patients often suffer from hypertension and/or diabetes mellitus, both of which may increase the CAVI. This parameter may be also increased after antidiabetic or antihypertensive treatment 39) ; therefore, the data for subjects with diabetes mellitus or hypertension were excluded from the present analysis. Notably, the CAVI values were significantly increased in the 248 patients with DLP and higher in both the PH and CH subgroups than in the controls. However, the analysis of the primary data revealed statistically significant differences in age, gender, waist circumference and BMI between the patients and controls; in particular, the subjects in the DLP group were older and had higher BMI and patients, and the CAVI values were also increased, although insignificantly, in the CH subgroup. The insignificant differences in the CAVI values observed between the controls and both subgroups of patients (CH, PH) are likely due to the decreased number of patients in these datasets as a result of the application of the propensity score method (i.e., the elimination of differences in age, gender and BMI between particular groups). Although the propensity score method provides a fully balanced structure for confounding factors between groups, it simultaneously decreases the sample size due to the need to remove patients outside the range of overlapping confounding factors. Hence, both the control and DLP groups (particularly the PH and CH subgroups) remained relatively small, and the differences in the CAVI values between the groups were statistically insignificant.
It is rather difficult to compare our results with the data reported by other authors, since no comparisons of the CAVI values among patients with DLP without any other risk factors and healthy Caucasian subjects have been published to date. Furthermore, it remains unclear whether the relationship between the range of overlapping confounding factors. In our analysis, the propensity score method for balancing the datasets and removing confounding factors (age, gender, BMI) was selected based on the significant differences in age distribution between the patients and controls (i.e., the groups only partially overlapped for age, which limits the application of regression adjustment).
There is no clear relationship between the CAVI and BP; the CAVI was introduced into clinical practice as a BP-independent parameter 16, 20, 26) . However, according to the findings of several studies, this value is indeed influenced by BP, although the effect is significantly lower than that observed for the PWV 13, 45) . For this reason, further linear regression adjustment of the CAVI values for diastolic blood pressure was adopted in this study for cases in which the DBP values were statistically significantly different between the matched groups. Even after excluding the variables of age, gender, BMI and BP, the CAVI values remained significantly increased among the DLP patients versus the control group. These findings did not differ between the controls and PH subgroup 42) . Moreover, a negative correlation has been reported between the CAVI and LDL-cholesterol values in subjects with incipient atherosclerosis 51) , and contradictory results are often obtained for the relationship between the CAVI and blood lipid levels in diabetics. Notably, Wang found an independent relationship between the CAVI and HDL-cholesterol levels in patients with diabetes mellitus type 2 48) , whereas other authors have not confirmed any independent relationships between the CAVI values and the total cholesterol, triglycerides, HDL-cholesterol and LDLcholesterol levels 52, 53) . Finally, an independent relationship has not been proven between the CAVI and total cholesterol levels in type 2 diabetics treated with regular hemodialysis 54) . The results regarding the relationship between the CAVI values and the blood lipid levels in other patient groups are also inconsistent. For example, a correlation was found between the CAVI and LDLcholesterol levels (as well as the total cholesterol/HDLcholesterol ratio) in patients with chest pain who undergo coronarography, whereas no relationships have been confirmed between the CAVI values and the total CAVI and DLP is causal. Indeed, although there is a significant correlation between the CAVI and cardiovascular risks 46) and independent relationships have been documented between the CAVI and other main risk factors for cardiovascular disease (hypertension, obesity, diabetes, smoking) 13, 16, 27, 44, 47, 48) , the relationship between the CAVI and the blood lipid levels has not been elucidated.
It has been reported that DLP and the CAVI are probably not closely linked directly and that DLP per se does not immediately increase arterial wall stiffness. For example, Takaki 49) demonstrated that the CAVI had a poor relationship with the total cholesterol and LDL-cholesterol levels and there are no correlations between the CAVI values and the triglyceride and HDL-cholesterol levels. In addition, Higashiyama 50) reported that, in patients without cardiovascular disorders exhibiting moderately increased LDL-cholesterol levels, the CAVI value correlates better with the highsensitivity C-reactive protein (hs-CRP) level than with the LDL-cholesterol level. Furthermore, in our previous study, we found no significant correlations between the blood lipid levels (total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides) and CAVI 62) . Consequently, elasticity is decreased and arterial stiffness, as measured by the CAVI, is increased.
There are several limitations associated with the present study. First, this study was not designed as a prospective case-control study. Nevertheless, the use of a propensity score analysis to obtain a balanced structure of confounding factors between the compared groups is a well-accepted statistical approach for overcoming differences between the study and control populations. Second, the application of the propensity score method substantially decreased the sample size due to the need to remove subjects outside the range of overlapping confounding factors and subsequently changed the structure of the balanced datasets in comparison to the primary datasets. Hence, both the control and DLP groups (particularly the PH and CH subgroups) remained relatively small, and caution is thus required when generalizing the results. Third, our study did not cover the energy balance (the total energy consumption/physical activity ratio), which may have helped to shed new light on the diverse results of previous studies as well as expand the scope of our findings to other cardiovascular risk factors, such as physical inactivity or the percentage of body fat 63) . Fourth, CAVI measurements do not take into consideration the BP of the central aorta (central BP), a prognostic factor predicting future cardiovascular events 22) .
Conclusion
In the present study, we demonstrated that the CAVI values are significantly increased in DLP patients without diabetes and/or hypertension in comparison with healthy controls. However, further large prospective case-control studies are required to confirm our findings.
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The authors declare no conflicts of interest. cholesterol, HDL-cholesterol or triglyceride levels 55) . Other authors have reported a weak positive correlation between the CAVI values and the total and LDLcholesterol levels in patients with chest pain 49) ; however, no correlations have been documented between the CAVI values and the total cholesterol, triglyceride and lipoprotein (a) levels in hemodialyzed patients 56) . Limited information is also available with respect to the correlation between the CAVI values and the blood lipid levels in the general population. A significant increase in the CAVI values was recently observed among patients with low HDL-cholesterol levels in a Chinese population 41) , while a simple regression analysis revealed a significant correlation between the CAVI values and the total cholesterol, LDL-cholesterol and triglyceride levels in a Japanese population, although this relationship disappeared in a multiple linear regression analysis adjusted for confounding factors 57) . The principle of CAVI measurement is based on the heartankle PWV; however, the relationship between DLP and the heart-ankle PWV has not yet been elucidated in detail. The only available research regarding this relationship in healthy persons found a significant positive association between the heart-ankle PWV and the plasma triglyceride levels, although no relationship was documented between the heart-ankle PWV and the total or HDL-cholesterol levels 58) . Although dyslipidemia (namely, increased LDLcholesterol) is one of the main risk factors for premature atherosclerosis and there is a correlation between the CAVI and cardiovascular risks 46) , the relationships between the blood lipid levels and the CAVI values remain obscure. In our set of DLP patients with no other risk factors, a statistically significant increase was observed in the CAVI values compared to that noted in the control subjects; however, it is possible that the increased CAVI values detected in these patients are not necessarily related to the cholesterol or triglyceride levels, although they are linked, for instance, to the presence of modified forms of lipids and lipoproteins or lipoprotein remnants. A recently published work proved that remnant lipoproteins are predictors of carotid and coronary atherosclerosis, as measured by the CAVI and IMT 59) . Other papers have reported an independent correlation between the CAVI and the oxidized form of Lp(a) in patients with hypertension 60) as well as an independent relationship between a decreased CAVI and decreased modified LDL level (serum amyloid A-low-density lipoprotein) in patients with metabolic syndrome 61) . It is therefore probable that the increased CAVI values observed in patients with DLP are due to the effects of the atherosclerotic process in the arterial wall, in which atherogenic and
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